Susquehanna International Group
BOLD

Susquehanna International Group’s Audentes Therapeutics, Inc BOLD Stock Holding History

Susquehanna International Group’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-69,600
Closed -$4.17M – 11365
2019
Q4 		$4.17M Buy
69,600
+24,722
+55% +$928K ﹤0.01% 3238
2019
Q3 		$1.26M Buy
44,878
+6,256
+16% +$214K ﹤0.01% 5196
2019
Q2 		$1.46M Buy
+38,622
New +$1.48M ﹤0.01% 4834

Susquehanna International Group's BOLD Position: Q1 2020 in Review

Susquehanna International Group sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 69,600 shares — an estimated $4.17M sold.

Susquehanna International Group first reported a position in BOLD in Q2 2019 and held it in 3 quarters. The position peaked at $4.17M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Susquehanna International Group reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Susquehanna International Group sold 69,600 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $4.17M.
  • Susquehanna International Group first reported a position in Audentes Therapeutics, Inc in Q2 2019 and held it in 3 quarters.
  • Susquehanna International Group's Audentes Therapeutics, Inc position peaked at $4.17M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.